Technical Analysis for SYRE - Spyre Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| B | 33.59 | -3.74% | -1.31 |
SYRE closed up 3.96 percent on Monday, April 29, 2024, on 68 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
Earnings due: May 9
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | -3.74% | |
| Crossed Above 50 DMA | Bullish | -3.74% | |
| Stochastic Buy Signal | Bullish | -3.74% | |
| Bollinger Band Squeeze | Range Contraction | -3.74% | |
| Oversold Stochastic | Weakness | -3.74% | |
| Bollinger Band Squeeze | Range Contraction | 0.07% | |
| NR7 | Range Contraction | 0.07% | |
| NR7-2 | Range Contraction | 0.07% | |
| Oversold Stochastic | Weakness | 0.07% | |
| Stochastic Buy Signal | Bullish | 3.43% |
| Alert | Time |
|---|---|
| 10 DMA Support | 28 minutes ago |
| Down 3% | 36 minutes ago |
| Fell Below 10 DMA | 36 minutes ago |
| 60 Minute Opening Range Breakdown | about 1 hour ago |
| Down 2 % | about 1 hour ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Spyre Therapeutics is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Immunology Antibodies Autoimmune Disease Monoclonal Antibody Antibody Inflammatory Bowel Disease
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Immunology Antibodies Autoimmune Disease Monoclonal Antibody Antibody Inflammatory Bowel Disease
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 47.97 |
| 52 Week Low | 2.66 |
| Average Volume | 533,261 |
| 200-Day Moving Average | 20.57 |
| 50-Day Moving Average | 34.86 |
| 20-Day Moving Average | 35.44 |
| 10-Day Moving Average | 34.00 |
| Average True Range | 2.89 |
| RSI (14) | 49.24 |
| ADX | 17.58 |
| +DI | 20.84 |
| -DI | 18.44 |
| Chandelier Exit (Long, 3 ATRs) | 32.16 |
| Chandelier Exit (Short, 3 ATRs) | 39.94 |
| Upper Bollinger Bands | 39.51 |
| Lower Bollinger Band | 31.37 |
| Percent B (%b) | 0.43 |
| BandWidth | 22.98 |
| MACD Line | -0.64 |
| MACD Signal Line | -0.26 |
| MACD Histogram | -0.386 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 38.54 | ||||
| Resistance 3 (R3) | 38.46 | 37.15 | 37.93 | ||
| Resistance 2 (R2) | 37.15 | 36.22 | 37.19 | 37.73 | |
| Resistance 1 (R1) | 36.02 | 35.65 | 36.59 | 36.11 | 37.53 |
| Pivot Point | 34.72 | 34.72 | 35.00 | 34.76 | 34.72 |
| Support 1 (S1) | 33.59 | 33.78 | 34.15 | 33.67 | 32.25 |
| Support 2 (S2) | 32.28 | 33.21 | 32.32 | 32.05 | |
| Support 3 (S3) | 31.15 | 32.28 | 31.85 | ||
| Support 4 (S4) | 31.24 |
